Official Journal of Research Center for Gastroenterology and Liver Diseases
Scopus by Title (Ref)
Articles that cite the referenced work, matched by title from the Scopus database.
Diagnostic, prognostic, and predictive cancer biomarkers in cancer theraputic approaches
Advances in Cancer Research
1 January 2026
Mridha P.
Small Molecule Inhibitors for Hepatocellular Carcinoma: Advances and Challenges
Molecules
September 2022
Kamal M.A.
Open Access
Genomic biomarkers to guide precision radiotherapy in prostate cancer
Prostate
August 2022
Sutera P.
All Open Access, Green
Marsdenia tenacissima Extract Induces Autophagy and Apoptosis of Hepatocellular Cells via MIF/mToR Signaling
Evidence Based Complementary and Alternative Medicine
2022
Lin S.
Open Access
Natural Products as PI3K/ Akt Inhibitors: Implications in Preventing Hepatocellular Carcinoma
Current Molecular Pharmacology
October 2021
Narayanankutty A.
2-Methoxyestradiol synergizes with Erlotinib to suppress hepatocellular carcinoma by disrupting the PLAGL2-EGFR-HIF-1/2α signaling loop
Pharmacological Research
July 2021
Zheng S.
Open Access
Mir-183-5p promotes hcc migration/invasion via increasing aerobic glycolysis
Oncotargets and Therapy
2021
Niu Y.
Open Access
Expression and clinical significance of ERCC1 and XPF in human hepatocellular carcinoma
Oncotargets and Therapy
2020
Liao X.
Open Access
Precise immunodetection of PTEN protein in human neoplasia
Cold Spring Harbor Perspectives in Medicine
December 2019
Pulido R.
Open Access
Progress in research on association between cell signal transduction pathways and hepatocellular carcinoma
World Chinese Journal of Digestology
8 November 2019
Chen C.
Open Access
Ecto-5′-nucleotidase (CD73) is a potential target of hepatocellular carcinoma
Journal of Cellular Physiology
July 2019
Shali S.
Relationship between EGFR expression and subcellular localization with cancer development and clinical outcome
Oncotarget
1 March 2019
Yan G.
Open Access
Evolving Systemic Therapy in Hepatocellular Carcinoma: Current Management and Opportunities for Integration With Radiotherapy
Seminars in Radiation Oncology
October 2018
Keane F.K.
Open Access
A Randomized Phase II Open-Label Multi-Institution Study of the Combination of Bevacizumab and Erlotinib Compared to Sorafenib in the First-Line Treatment of Patients with Advanced Hepatocellular Carcinoma
Oncology Switzerland
1 May 2018
Thomas M.B.
All Open Access, Green
Anti-tumor effects of NVP-BKM120 alone or in combination with MEK162 in biliary tract cancer
Cancer Letters
28 December 2017
Jin L.
Exploitation of Gene Expression and Cancer Biomarkers in Paving the Path to Era of Personalized Medicine
Genomics Proteomics and Bioinformatics
August 2017
Kamel H.F.M.
Open Access
Diagnostic and prognostic values of contrast-enhanced ultrasound in breast cancer: A retrospective study
Oncotargets and Therapy
22 February 2017
Zhao Y.X.
Open Access
Genetic alterations in hepatocellular carcinoma: An update
World Journal of Gastroenterology
7 November 2016
Niu Z.S.
Open Access
EGFR and SYNE2 are associated with p21 expression and SYNE2 variants predict post-operative clinical outcomes in HBV-related hepatocellular carcinoma
Scientific Reports
9 August 2016
Han C.
Open Access
Roles of XRCC1/XPD/ERCC1 Polymorphisms in Predicting Prognosis of Hepatocellular Carcinoma in Patients Receiving Transcatheter Arterial Chemoembolization
Genetic Testing and Molecular Biomarkers
1 April 2016
Wang X.C.
Genome-wide association study identified PLCE1- rs2797992 and EDFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in Guangxi
American Journal of Translational Research
2016
Liao X.
Search: A phase III, randomized, double-blind, placebo-controlled trial of sorafenib plus erlotinib in patients with advanced hepatocellular carcinoma
Journal of Clinical Oncology
20 February 2015
Zhu A.X.
All Open Access, Green
Hepatocellular Carcinoma: Progress in signaling pathways and therapeutic targets
Academic Journal of Second Military Medical University
2015
Wu J.F.
Epidermal growth factor receptor pathway polymorphisms and the prognosis of hepatocellular carcinoma
American Journal of Cancer Research
2015
Wang W.